ETOPOSIDE PHOSPHATE

1635 reported adverse events

These side effects are most commonly reported by patients taking ETOPOSIDE PHOSPHATE:

# Side effect Count
0 OFF LABEL USE 200
1 DISEASE PROGRESSION 163
2 PRODUCT USE IN UNAPPROVED INDICATION 93
3 ACUTE KIDNEY INJURY 83
4 THROMBOCYTOPENIA 82
5 FEBRILE NEUTROPENIA 72
6 PYREXIA 71
7 DRUG INEFFECTIVE 68
8 MALIGNANT NEOPLASM PROGRESSION 68
9 NEUTROPENIA 61
See all common reactions for ETOPOSIDE PHOSPHATE

ETOPOSIDE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GREY ZONE LYMPHOMA 3 0.3333
1 EARLY REPOLARISATION SYNDROME 2 0.2000
2 MEASLES POST VACCINE 2 0.1538
3 PREALBUMIN ABNORMAL 2 0.1333
4 PROCTITIS BACTERIAL 2 0.1250
5 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA RECURRENT 2 0.1176
6 SCOPULARIOPSIS INFECTION 4 0.0889
7 HEPATITIS G 2 0.0714
8 DILATATION INTRAHEPATIC DUCT ACQUIRED 20 0.0685
9 ANTITHROMBIN III DEFICIENCY 6 0.0674
See all enriched reactions for ETOPOSIDE PHOSPHATE